On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility will give Lilly the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials.

The first-ever facility of its kind, combining research and manufacturing in a single location, the Medicine Foundry will be located in Indiana’s  LEAP Research and Innovation District in Lebanon, Indiana and will expand the company’s investment there to more than $13 billion.